Clinical Trial Update: Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating hydroxychloroquine for HIV-infected individuals with discordant CD4 responses on HAART; the current status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 1 | Status: UNKNOWN